Clinical utility of the risperidone formulations in the management of schizophrenia

References

• ColpaertFCDiscovering risperidone: the LSD model of psychopathologyNat Rev Drug Discov20032431532012669030
   PubMed Web of Science ®Google Scholar
• Van SchaickEALechatPRemmerieBMKoGLasseterKCMannaertEPharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteersClin Ther20032561687169912860492
   PubMed Web of Science ®Google Scholar
• NormannCSchmaussMBakriNGerweMSchreinerAInitial treatment of severe acute psychosis with fast orally disintegrating risperidone tabletsPharmacopsychiatry200639620921217124642
   PubMed Web of Science ®Google Scholar
• LimHKKimJJPaeCULeeCULeeCPaikIHComparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective studyNeuropsychobiology2010622818620523078
   PubMed Web of Science ®Google Scholar
• MegensAAAwoutersFHSchotteASurvey on the pharmacodynamics of the new antipsychotic risperidonePsychopharmacology (Berl)199411419237531353
   PubMed Web of Science ®Google Scholar
• LiCXiaJWangJRisperidone dose for schizophreniaCochrane Database Syst Rev10720094CD00747419821422
   PubMed Web of Science ®Google Scholar
• FleischhackerWWCzoborPHummerMKemmlerGKohnenRVolavkaJPlacebo or active control trials of antipsychotic drugs?Arch Gen Psychiatry200360545846412742866
   PubMed Web of Science ®Google Scholar
• WoodsSWGueorguievaRVBakerCBMakuchRWControl group bias in randomized atypical antipsychotic medication trials for schizophreniaArch Gen Psychiatry200562996197016143728
   PubMed Web of Science ®Google Scholar
• RattehalliRDJayaramMBSmithMRisperidone versus placebo for schizophreniaCochrane Database Syst Rev12020101CD00691820091611
   PubMed Web of Science ®Google Scholar
• LeuchtSArbterDEngelRRKisslingWDavisJMHow effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trialsMol Psychiatry200914442944718180760
   PubMed Web of Science ®Google Scholar
• HunterRHJoyCBKennedyEGilbodySMSongFRisperidone versus typical antipsychotic medication for schizophreniaCochrane Database Syst Rev20032CD00044012804396
   PubMed Web of Science ®Google Scholar
• KennedyESongFHunterRClarkeAGilbodySRisperidone versus typical antipsychotic medication for schizophreniaCochrane Database Syst Rev20002CD00044010796543
   PubMedGoogle Scholar
• Crespo-FacorroBPérez-IglesiasROMataIEffectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparisonJ Psychopharmacol201110.1177/0269881110388332.
   Web of Science ®Google Scholar
• KomossaKRummel-KlugeCSchwarzSSchmidFHungerHKisslingWLeuchtSRisperidone versus other atypical antipsychotics for schizophreniaCochrane Database Syst Rev20111CD00662621249678
   PubMed Web of Science ®Google Scholar
• LeuchtSCorvesCArbterDEngelRRLiCDavisJMSecond-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysisLancet20093739657314119058842
   PubMed Web of Science ®Google Scholar
• LeuchtSKomossaKRummel-KlugeCA meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophreniaAm J Psychiatry2009166215216319015230
   PubMed Web of Science ®Google Scholar
• NaberDLambertMThe CATIE and CUtLASS studies in schizophrenia: results and implications for cliniciansCNS Drugs200923864965919594194
   PubMed Web of Science ®Google Scholar
• ManschreckTCBoshesRAThe CATIE schizophrenia trial: results, impact, controversyHarv Rev Psychiatry200715524525817924259
   PubMed Web of Science ®Google Scholar
• TaylorDPsychopharmacology and adverse effects of antipsychotic long-acting injections: a reviewBr J Psychiatry Suppl200952S131919880912
   PubMedGoogle Scholar
• KaneJMEerdekensMLindenmayerJPKeithSJLesemMKarcherKLong-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychoticAm J Psychiatry200316061125113212777271
   PubMed Web of Science ®Google Scholar
• ChuePEerdekensMAugustynsILachauxBMolcanPErikssonLComparative efficacy and safety of long-acting risperidone and risperidone oral tabletsEur Neuropsychopharmacol200515111111715572280
   PubMed Web of Science ®Google Scholar
• WillisMSvenssonMLöthgrenMErikssonBBerntssonAPerssonUThe impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in SwedenEur J Health Econ201011658559420084535
   PubMed Web of Science ®Google Scholar
• ApiquianRCórdobaRLouzãMClinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin AmericaNeuropsychiatr Dis Treat20107192621326651
   PubMed Web of Science ®Google Scholar
• PeuskensJOlivaresJMPecenakJTreatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countriesCurr Med Res Opin201026350150920014981
   PubMed Web of Science ®Google Scholar
• ParelladaEKouniakisFSiurkuteASchreinerADonLSafety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disordersInt Clin Psychopharmacol201025314915420305567
   PubMed Web of Science ®Google Scholar
• RubioGMartinezIPonceGJimenez-ArrieroMALopez-MunozFAlamoCLong-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidityCan J Psychiatry200651853153916933590
   PubMed Web of Science ®Google Scholar
• EmsleyRMedoriRKoenLOosthuizenPPNiehausDRabinowitzJLong-acting injectable risperidone in the treatment of subjects with recent-onset psychosisJ Clin Psychopharm2008282210213
   Web of Science ®Google Scholar
• FleischhackerWWSecond-generation antipsychotic long-acting injections: systematic reviewBr J Psychiatry Suppl200952S293619880914
   PubMedGoogle Scholar
• BeitchmanJHChildhood schizophrenia: a review and comparison of adult onset schizophreniaPsychiatric Clin North Am198584793814
   Web of Science ®Google Scholar
• MadaanVRisperidone: a review of efficacy studies in adolescents with schizophreniaDrugs Today (Barc)2009451556219271032
   PubMed Web of Science ®Google Scholar
• HaasMUnisASArmenterosJCopenhaverMDQuirozJAKushnerSFA 6-week, randomized, double blind, placebo controlled study of the efficacy and safety of risperidone in adolescents with schizophreniaJ Child Adolesc Psychopharmacol200919661162120035579
   PubMed Web of Science ®Google Scholar
• PandinaGKushnerSSingerJComparison of two risperidone dose ranges inadolescents with schizophrenia [abstract]54th Annu Meet Am Acad Child Adolesc PsychiatryOctober 23–28, 2007Boston, MA
   Google Scholar
• HellingsJAZarconeJRValdovinosMGReeseRMGaughanESchroederSRRisperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disordersJ Child Adolesc Psychopharmacol200515688589216379508
   PubMed Web of Science ®Google Scholar
• TorenPLoarNWeizmanAUse of atypical neuroleptics in child and adolescent psychiatryJ Clin Psychiatry199859126446569921698
   PubMed Web of Science ®Google Scholar
• ArmenterosJLWhitakerAHWeliksonMStedgeDJGormanJRisperidone in adolescents with schizophrenia:an open pilot studyJ Am Acad Child Adolesc Psychiatry19973656947009136505
   PubMed Web of Science ®Google Scholar
• QuintanaHKeshavanMCase study: risperidone in children and adolescents with schizophreniaJ Am Acad Child Adolesc Psychiatry19953410129212967592266
   PubMed Web of Science ®Google Scholar
• CorrellCUPenzerJBParikhUHRecognizing and monitoring adverse events of second-generation antipsychotics in children and adolescentsChild Adolesc Psychiatric Clin N Am2006151177206
   Web of Science ®Google Scholar
• LloydAHoranWBorgaroSRStokesJMPoggeDLHarveyPDPredictors of medication compliance after hospital discharge in adolescent psychiatric patientsJ Child Adolesc Psychopharmacol1998821331419730079
   PubMed Web of Science ®Google Scholar
• CiprianiABosoMBarbuiCClozapine combined with different antipsychotic drugs for treatment resistant schizophreniaCochrane Database Syst Rev20093CD00632419588385
   PubMed Web of Science ®Google Scholar
• BarbuiCSignorettiAMulèSBosoMCiprianiADoes the addition of a second antipsychotic drug improve clozapine treatment?Schizophr Bull200935245846818436527
   PubMed Web of Science ®Google Scholar
• HouthoofdSAMorrensMSabbeBGCognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorderClin Ther20083091565158918840365
   PubMed Web of Science ®Google Scholar
• ChoSJYookKKimBMirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trialProg Neuropsychopharmacol Biol Psychiatry201135120821121095214
   PubMed Web of Science ®Google Scholar
• AbbasiSHBehpourniaHGhoreshiAThe effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trialSchizophr Res20101162–310110619959338
   PubMed Web of Science ®Google Scholar
• TakahashiHSugitaTHiguchiHShimizuTFluvoxamine augmentation in risperidone-resistant schizophrenia: an open trialHum Psychopharmacol2002172959812404698
   PubMed Web of Science ®Google Scholar
• BerkMGamaCSSundramSMirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trialHum Psychopharmacol200924323323819330802
   PubMed Web of Science ®Google Scholar
• StipENovel antipsychotics: issues and controversies. Typicality of atypical antipsychoticsJ Psychiatry Neurosci200025213715310740987
   PubMed Web of Science ®Google Scholar
• MedscapeDrugs, Diseases and Procedures: Risperidone Available at: http://reference.medscape.com/drug/risperdal-consta-risperidone-342986#0
   Google Scholar
• CorrellCULeuchtSKaneJMLower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studiesAm J Psychiatry2004161341442514992963
   PubMed Web of Science ®Google Scholar
• JesteDVLacroJPBaileyARockwellEHarrisMJCaligiuriMPLower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patientsJ Am Geriatr Soc199947671671910366172
   PubMed Web of Science ®Google Scholar
• NovickDHaroJMBertschJHaddadPMIncidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes studyJ Clin Psychopharmacol201030553154020814320
   PubMed Web of Science ®Google Scholar
• WootenJMetabolic effects of atypical antipsychoticsSouth Med J2007100877177217713300
   PubMed Web of Science ®Google Scholar
• Consensus development conference on antipsychotic drugs and obesity and diabetes American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of ObesityJ Clin Psychiatry200465226727215003083
   PubMed Web of Science ®Google Scholar
• SimonVvan WinkelRDe HertMAre weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature reviewJ Clin Psychiatry20097071041105019653979
   PubMed Web of Science ®Google Scholar
• SmithMHopkinsDPevelerRCHoltRIWoodwardMIsmailKFirst- vs second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysisBr J Psychiatry2008192640641118515889
   PubMed Web of Science ®Google Scholar
• MadhusoodananSParidaSJimenezCHyperprolactinemia associated with psychotropics – a reviewHum Psychopharmacol201025428129720521318
   PubMed Web of Science ®Google Scholar
• EdwardsSJSmithCJTolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trialsClin Ther200931Pt 11345135919698898
   PubMed Web of Science ®Google Scholar
• TrollorJNChenXSachdevPSNeuroleptic malignant syndrome associated with atypical antipsychotic drugsCNS Drugs200923647749219480467
   PubMed Web of Science ®Google Scholar
• TaylorDPatonCKapurSThe Maudsley Prescribing guidelines10th edLondon, UKInforma Healthcare2009
   Google Scholar
• NewcomerJWHauptDWFucetolaRAbnormalities in glucose regulation during antipsychotic treatment of schizophreniaArch Gen Psychiatry200259433734511926934
   PubMed Web of Science ®Google Scholar
• OlfsonMMarcusSCCorey-LislePTuomariAVHinesPL’ItalienGJHyperlipidemia following treatment with antipsychotic medicationsAm J Psychiatry2006163101821182517012695
   PubMed Web of Science ®Google Scholar
• Rummel-KlugeCKomossaKSchwarzSHead-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysisSchizophr Res20101232–322523320692814
   PubMed Web of Science ®Google Scholar
• CarpenterWTKoenigJIThe evolution of drug development in schizophrenia: past issues and future opportunitiesNeuropsychopharmacology20083392061207918046305
   PubMed Web of Science ®Google Scholar
• GeddesJFreemantleNHarrisonPBebbingtonPAtypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisBMJ2000321727313711376
   PubMed Web of Science ®Google Scholar
• DavisJMChenNGlickIDA meta-analysis of the efficacy of second-generation antipsychoticsArch Gen Psychiatry200360655356412796218
   PubMed Web of Science ®Google Scholar
• TiihonenJWahlbeckKLönnqvistJEffectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyBMJ20063337561224
   PubMed Web of Science ®Google Scholar
• HaroJMNovickDSuarezDAlonsoJLépineJPRatcliffeMSOHO Study GroupRemission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes studyJ Clin Psychopharmacol200626657157817110813
   PubMed Web of Science ®Google Scholar